Clinical Trials on the Use of I-O and TKIs in RCC

Michael B. Atkins MD at Georgetown Lombardi Comprehensive Cancer Center, Scholl Professor and Vice Chair Department of Oncology provides some recent trial investigations using immuno-oncology and TKIs in renal cell carcinoma.